Showing results (71-80 of 205) with videos related to

Sort By:
Pageof 21
Cancer|March 22, 2016
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicityCharles A Schiffer, Jorge E Cortes, Andreas Hochhaus, et al.
Scientific Reports|March 1, 2018
Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KITJaideep B Bharate, Nicholas McConnell, Gunaganti Naresh, et al.
The Journal of Experimental Medicine|March 23, 2005
Granulocyte/macrophage colony-stimulating factor and accessory cells modulate radioprotection by purified hematopoietic cellsTamiko R Katsumoto, Jennifer Duda, Andrew Kim, et al.
Annals of Hematology|May 24, 2017
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratiosGiuseppe Saglio, Philipp le Coutre, Jorge Cortes, et al.
Cureus|June 12, 2023
Telemedicine Evaluation of Hip AilmentsRock P Vomer, Emma York, Kristina DeMatas, et al.
Cancer|June 19, 2009
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R)Hagop Kantarjian, Ricardo Pasquini, Vincent Lévy, et al.
Genes & Development|July 3, 2010
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewalZhen Zhao, Johannes Zuber, Ernesto Diaz-Flores, et al.
AIDS Research and Human Retroviruses|August 9, 2002
HIV type 1 glycoprotein 120 inhibits cardiac myocyte contractionFuhua Chen, Kevin Shannon, Shulan Ding, et al.
Cancer Discovery|December 24, 2013
MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addictionJennifer Asmussen, Elisabeth A Lasater, Cheryl Tajon, et al.
American Journal of Hematology|May 20, 2016
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034Neil P Shah, Philippe Rousselot, Charles Schiffer, et al.
Pageof 21